In this paper, we conjugated CD-PLLD with FA to synthesize a FA-targeted drug and gene dual carrier, and then use this carrier to co-deliver DOC and MMP-9 for NPC treatment. Here, MMP9 is linked to nasopharyngeal carcinoma.